Cabled not Disabled

Cabled not Disabled

Cabled not Disabled

COVID-19 has been particularly cruel to segments of the population, including minorities, nursing home residents and the disabled.

As the COVID-19 pandemic continues to spread across the globe, young people with disabilities are facing unique challenges. The threat of contracting the virus has led to schools and businesses closing, citizens being told to stay home and shelter in place and hospitals being overrun. 

Emerging research on COVID-19 shows that the coronavirus pandemic has increased psychological distress both in the general population and among high-risk groups. Behaviours such as physical distancing, as well as their social and economic impacts, are worsening mental health consequences.

Research on the psychological impact of mass trauma (e.g., natural disasters, flu outbreaks) suggests that the pandemic might particularly harm the mental health of marginalised populations who have less access to socioeconomic resources and supportive social networks.

There are unique stressors and challenges that could worsen mental health for people with disabilities during the COVID-19 crisis.

Sickcare USA, Inc has been lax in addressing behavioural health, social determinants and those with disabilities, which have been amplified by the COVID pandemic.

The collision of media, information and communications technologies (MICT) and BIG DIGITAL might be a solution for sickcare, workforce development and education.

Cabled not Disabled is a new reality. But, unlike a vaccine, those with disabilities will still be at risk in the post-COVID 4th industrial revolution.

Making it happen will require a new global cyber-nervous system, education and training, universal broadband access, different customer service requirements and innovative business models.

Creating a better customer experience will mean micturating on it, much like pissing on doctor burnout.

Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs and Facebook

Share this article

Leave your comments

Post comment as a guest

0
terms and condition.
  • Mark K

    Excellent article

  • David Smith

    Good read

Share this article

Arlen Meyers, MD, MBA

Healthcare Expert

Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.

   

Latest Articles

View all
  • Science
  • Technology
  • Companies
  • Environment
  • Global Economy
  • Finance
  • Politics
  • Society